TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed AML patients with diverse mutationsSafety continues to be a notable hallmark of ...

MRD-negative status in first four heavily treated patients with "off the shelf" product ...

Drug development represented the largest market share. The in-silico clinical trials market is expected to reach $6.39b by ...

Artificial intelligence is rapidly transforming clinical medicine, with AI-powered tools increasingly being used for ...

The Minister for Foreign Affairs, Mr . Samuel Okudzeto Ablakwa has called for an integrated approach to drug control, ...

Microphysiological systems help address the shortcomings of animal models for mAb development, and CN Bio is taking an active ...

Researchers are reporting that an existing drug can roll back key signs of Alzheimer’s disease in mice, restoring memory ...

Marijuana breeders may be able to design new strains and speed up their growing cycles by utilizing artificial intelligence ...

What do local members of Congress think about the issues of the day? Answering that is the goal of the Southern California News Group editorial board project In-House Opinions.

It’s about co-creating science.” The event highlighted pathogen research discoveries and pandemic prevention efforts from ...

Patients with hidradenitis suppurativa (HS) who started on or switched to biosimilar adalimumab experienced lower treatment success and lost response more quickly, according to an Australian study ...